Therefore, this work reveals a new mechanism of cell tolerance to alkylation-based chemotherapy in SCLC, through the promotion of a dealkylation repair pathway induced by the elevation of RNF113A E3 ligase activity. The gene discussed is RNF113A; the disease is small cell lung carcinoma.